Showing 861-870 of 1090 results for "".
- Johnson & Johnson Vision Receives Approval in Canada for First Drug-Releasing Contact Lens for Vision Correction and Allergic Eye Itchhttps://modernod.com/news/johnson-johnson-vision-receives-approval-in-canada-for-first-drug-releasing-contact-lens-for-vision-correction-and-allergic-eye-itch/2479117/Johnson & Johnson Vision received Health Canada approval for the first and only daily disposable contact lens for vision correction in patients who experience itchy allergy eyes due to allergic conjunctivitis: Acuvue Theravision with Ketotifen.1 The lens contains an H1 hista
- Roche, Regeneron’s REGEN-COV Cuts Symptomatic COVID-19 by 81% Among Household Contactshttps://modernod.com/news/roche-regenerons-regen-cov-cuts-symptomatic-covid-19-by-81-among-household-contacts/2479071/Regeneron Pharmaceuticals and partner Roche reported positive results from a phase 3 study, showing that a subcutaneous formulation of the antibody cocktail REGEN-COV (casirivimab with imdevimab) reduced the risk and burden of COVID-19 among household contacts of SARS-CoV-2-
- J&J Vision Announces Collaboration with Menicon to Bring Forward Contact Lenses for Childrenhttps://modernod.com/news/jj-vision-announces-collaboration-with-menicon-to-bring-forward-contact-lenses-for-children/2479057/Johnson & Johnson Vision announced a global strategic collaboration with Menicon, a manufacturer of contact lenses. As part of the collaboration, Menicon will develop and manufacture the contact lenses to help manage the progression of myopia in children. Johnson & Johnson Vision will foc
- Report: Contact Lenses to Advance Well Beyond Refractive Error Correctionhttps://modernod.com/news/report-contact-lenses-to-advance-well-beyond-refractive-error-correction/2479024/A newly-published paper represents one of the most comprehensive reviews of advancements to come in contact lenses, according to the Centre for Ocular Research & Education (CORE).
- Johnson & Johnson Vision Receives Approval in Japan for First Drug-Releasing Combination Contact Lens for Vision Correction and Allergic Eye Itchhttps://modernod.com/news/johnson-johnson-vision-receives-approval-in-japan-for-first-drug-releasing-combination-contact-lens-for-vision-correction-and-allergic-eye-itch/2479010/Johnson & Johnson Vision announced approval from the Japanese Ministry of Health, Labour and Welfare (MHLW) for the first and only vision correction contact lens that relieves allergic eye itch: Acuvue Theravision with Ketotifen. The lens contains ketotifen, an H1 histamine receptor antagonis
- CooperVision: Clariti 1 day Becomes First Net Plastic Neutral Contact Lens in the UShttps://modernod.com/news/coopervision-clariti-1-day-becomes-first-net-plastic-neutral-contact-lens-in-the-us/2478971/To provide an easy way for eye care professionals and their patients to be more sustainable, CooperVision announced a partnership with Plastic Bank that makes its clariti 1 day family the first net plastic neutral contact lenses.1 Plastic Bank is a social enterprise that builds
- Alcon Launches Precision1 for Astigmatism Contact Lenses in the UShttps://modernod.com/news/alcon-launches-precision1-for-astigmatism-contact-lenses-in-the-us/2478780/Alcon announced the US launch of Precision1 for Astigmatism, a daily disposable, silicone hydrogel (SiHy) contact lens designed for astigmatic patients. “Precision1, with its cutting-edge Smartsurface technology, has become the fastest-growing daily disposable contact lens brand in the U.S
- Smart Contact Lens Targets Vision Improvement for Those With Impairmentshttps://modernod.com/news/smart-contact-lens-targets-vision-improvement-for-those-with-impairments/2478766/A contact lens that operates like a smartphone in the eye was the breakout but not-yet-ready-for-prime-time health tech at Consumer Electronics Show (CES) this year, according to a Medscape report. The device wields computing and imaging p
- Azura Ophthalmics Announces Primary Endpoints Met in Phase 2 Trial of Investigational Treatment for Contact Lens Discomforthttps://modernod.com/news/azura-ophthalmics-announces-primary-endpoints-met-in-phase-2-trial-of-investigational-treatment-for-contact-lens-discomfort/2478686/Azura Ophthalmics announced topline results from a phase 2 clinical trial evaluating the company’s investigational therapy for the treatment of contact lens discomfort (CLD). The ECLIPTIC study examining Azura’s lead asset, AZR-MD-001, met its primary endpoints by showing statistically significan
- Largest Study on Children’s Soft Contact Lens Wear Safety Shows Very Low Complication Rateshttps://modernod.com/news/largest-study-on-childrens-soft-contact-lens-wear-safety-shows-very-low-complication-rates/2478654/The largest retrospective study of its kind has found very low complication rates in children who wear soft contact lenses, similar to rates in adults.1 The